Start SIP in
AJOONI
Performance
- Low
- ₹7
- High
- ₹7
- 52 Week Low
- ₹4
- 52 Week High
- ₹10
- Open Price₹7
- Previous Close₹7
- Volume352,154
Investment Returns
- Over 1 Month -7.2%
- Over 3 Month -4.45%
- Over 6 Month + 1.14%
- Over 1 Year + 18.17%
Smart Investing Starts Here Start SIP with Ajooni Biotech for Steady Growth!
Ajooni Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.8
- PEG Ratio
- 0.8
- Market Cap Cr
- 122
- P/B Ratio
- 1.5
- Average True Range
- 0.41
- EPS
- 0.16
- Dividend Yield
- 0
- MACD Signal
- -0.16
- RSI
- 48.61
- MFI
- 49.8
Ajooni Biotech Financials
Ajooni Biotech Technicals
EMA & SMA
Current Price
₹7.09
+
0.05
(0.71%)

-
- Bullish Moving Average 6
-
- Bearish Moving Average 10
- 20 Day
- ₹7.08
- 50 Day
- ₹7.32
- 100 Day
- ₹7.43
- 200 Day
- ₹7.17
Resistance and Support
7.08
- R3 7.39
- R2 7.28
- R1 7.19
- S1 6.99
- S2 6.88
- S3 6.79
Ajooni Biotech Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-13 | Quarterly Results | |
2025-01-03 | To consider Fund Raising & Others | (Revised) To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
2024-11-13 | Quarterly Results | |
2024-08-16 | Others | To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
2024-08-09 | Quarterly Results |
Ajooni Biotech F&O
About Ajooni Biotech
- NSE Symbol
- AJOONI
- BSE Symbol
- Managing Director & CFO
- Mr. Jasjot Singh
- ISIN
- INE820Y01021
Similar Stocks to Ajooni Biotech
Ajooni Biotech FAQs
Ajooni Biotech share price is ₹7 As on 22 February, 2025 | 21:18
The Market Cap of Ajooni Biotech is ₹122.1 Cr As on 22 February, 2025 | 21:18
The P/E ratio of Ajooni Biotech is 44.8 As on 22 February, 2025 | 21:18
The PB ratio of Ajooni Biotech is 1.5 As on 22 February, 2025 | 21:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.